Carlos Benitéz‐Buelga

Statistics

Publications

Citations

810

H-Index

Active since

2014

Affiliations

Spanish National Cancer Research Centre(Current)

Centre for Biomedical Network Research on Rare Diseases

Science for Life Laboratory

Universidad Autónoma de Madrid

Karolinska Institutet

Carlos Benitéz‐Buelga is an author at Spanish National Cancer Research Centre specializing in molecular oncology, telomere dysfunction, and telomere biology.

ORCID

Publications per year

2014–2024

Publications

Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation

Torkild Visnes, Armando Cázares‐Körner, Wenjing Hao et al. · Science · 2018 · 233 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like families

Oriol Calvete, Paula Martínez, Pablo García‐Pavía et al. · Nature Communications · 2015 · 165 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia

Christian Bär, Juan Manuel Povedano, Rosa Serrano et al. · Blood · 2016 · 110 citations · Full text

Medicine, Hematology, Molecular Biology +16

Small-molecule activation of OGG1 increases oxidative DNA damage repair by gaining a new function

Maurice Michel, Carlos Benitéz‐Buelga, Patricia A. Calvo et al. · Science · 2022 · 75 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Small molecule inhibitor of OGG1 blocks oxidative DNA damage repair at telomeres and potentiates methotrexate anticancer effects

Juan Miguel Baquero, Carlos Benitéz‐Buelga, Varshni Rajagopal et al. · Scientific Reports · 2021 · 41 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

1–5 of 15